Abiopharma

New Form 8-K - BioCardia, Inc. Filed: 2025-07-02 AccNo: 0001437749-25-021906 Size: 402 KB Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 4 - NEUROONE MEDICAL TECHNOLOGIES Corp Filed: 2025-07-02 AccNo: 0001709738-25-000008 Size: 7 KB

New Form 4 - Merck & Co., Inc. Filed: 2025-07-02 AccNo: 0001127602-25-018465 Size: 6 KB

New Form 4 - Merck & Co., Inc. Filed: 2025-07-02 AccNo: 0001127602-25-018463 Size: 6 KB

New Form 4 - Merck & Co., Inc. Filed: 2025-07-02 AccNo: 0001127602-25-018460 Size: 6 KB

New Form 6-K - DR REDDYS LABORATORIES LTD Filed: 2025-07-02 AccNo: 0001575872-25-000440 Size: 5 MB

New Form 6-K - I-Mab Filed: 2025-07-02 AccNo: 0000950170-25-092603 Size: 25 MB

I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025

FTRE Shareholders Have the Right to Lead the Fortrea Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group Before the Final Deadline - FTRE

Hemostemix’s VesCell Sales are Legal in Florida as it Pivots to Allow Non-FDA Approved Stem Cell Treatments!

New Form 4 - Flora Growth Corp. Filed: 2025-07-02 AccNo: 0000912282-25-000735 Size: 7 KB

Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma

New Form 4 - Serina Therapeutics, Inc. Filed: 2025-07-02 AccNo: 0001708599-25-000067 Size: 8 KB

New Form 4 - NEUROONE MEDICAL TECHNOLOGIES Corp Filed: 2025-07-02 AccNo: 0001540354-25-000007 Size: 7 KB

New Form 4 - Flora Growth Corp. Filed: 2025-07-02 AccNo: 0000912282-25-000733 Size: 7 KB